Cargando…

Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database

Purpose: Fibrosarcoma (FS) is a rare and malignant tumor that can occur in a variety of anatomic sites. The goal of this study is to use the National Cancer Database (NCDB) to analyze various factors affecting overall survival in FS and to be one of the rare studies to characterize the significance...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahl, Mary, Aurit, Sarah J, Silberstein, Peter T, Gootee, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631251/
https://www.ncbi.nlm.nih.gov/pubmed/34873506
http://dx.doi.org/10.7759/cureus.19163
_version_ 1784607515895398400
author Dahl, Mary
Aurit, Sarah J
Silberstein, Peter T
Gootee, Jonathan
author_facet Dahl, Mary
Aurit, Sarah J
Silberstein, Peter T
Gootee, Jonathan
author_sort Dahl, Mary
collection PubMed
description Purpose: Fibrosarcoma (FS) is a rare and malignant tumor that can occur in a variety of anatomic sites. The goal of this study is to use the National Cancer Database (NCDB) to analyze various factors affecting overall survival in FS and to be one of the rare studies to characterize the significance of the primary anatomic sites. Methods: The study cohort included 2,278 patients diagnosed with fibrosarcoma who received surgery from the NCDB. Kaplan-Meier curves, log-rank tests, and a multivariable Cox proportional hazard model were used to analyze the significance of factors affecting overall survival. Results: The head, face, and neck (HR = 1.44; 95% CI: 1.01-2.05; P = 0.046) and thorax anatomical sites (HR = 1.33; 95% CI: 1.02-1.73; P = 0.035) had a higher increased risk of death in comparison to the lower limb and hip. Compared to patients with private insurance, patients without insurance (HR = 1.99; 95% CI: 1.22 to 3.25; P = 0.006) and patients with Medicaid (HR = 1.99; 95% CI: 1.37 to 2.90; P < 0.001) had decreased overall survival. Patients associated with a zip code-level median household income ≥ $63,000 had a decreased risk of mortality when compared to lower income groups. Conclusion: In general, older patients with comorbidities, advanced-stage disease, and larger tumors who did not have private insurance and were from areas associated with lower income levels had poorer overall survival. No significant difference in overall survival was associated with receipt of neoadjuvant chemotherapy or neoadjuvant radiation.
format Online
Article
Text
id pubmed-8631251
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-86312512021-12-05 Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database Dahl, Mary Aurit, Sarah J Silberstein, Peter T Gootee, Jonathan Cureus Oncology Purpose: Fibrosarcoma (FS) is a rare and malignant tumor that can occur in a variety of anatomic sites. The goal of this study is to use the National Cancer Database (NCDB) to analyze various factors affecting overall survival in FS and to be one of the rare studies to characterize the significance of the primary anatomic sites. Methods: The study cohort included 2,278 patients diagnosed with fibrosarcoma who received surgery from the NCDB. Kaplan-Meier curves, log-rank tests, and a multivariable Cox proportional hazard model were used to analyze the significance of factors affecting overall survival. Results: The head, face, and neck (HR = 1.44; 95% CI: 1.01-2.05; P = 0.046) and thorax anatomical sites (HR = 1.33; 95% CI: 1.02-1.73; P = 0.035) had a higher increased risk of death in comparison to the lower limb and hip. Compared to patients with private insurance, patients without insurance (HR = 1.99; 95% CI: 1.22 to 3.25; P = 0.006) and patients with Medicaid (HR = 1.99; 95% CI: 1.37 to 2.90; P < 0.001) had decreased overall survival. Patients associated with a zip code-level median household income ≥ $63,000 had a decreased risk of mortality when compared to lower income groups. Conclusion: In general, older patients with comorbidities, advanced-stage disease, and larger tumors who did not have private insurance and were from areas associated with lower income levels had poorer overall survival. No significant difference in overall survival was associated with receipt of neoadjuvant chemotherapy or neoadjuvant radiation. Cureus 2021-10-31 /pmc/articles/PMC8631251/ /pubmed/34873506 http://dx.doi.org/10.7759/cureus.19163 Text en Copyright © 2021, Dahl et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Oncology
Dahl, Mary
Aurit, Sarah J
Silberstein, Peter T
Gootee, Jonathan
Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database
title Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database
title_full Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database
title_fullStr Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database
title_full_unstemmed Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database
title_short Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database
title_sort primary site and other prognostic factors for fibrosarcoma: an analysis of the national cancer database
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631251/
https://www.ncbi.nlm.nih.gov/pubmed/34873506
http://dx.doi.org/10.7759/cureus.19163
work_keys_str_mv AT dahlmary primarysiteandotherprognosticfactorsforfibrosarcomaananalysisofthenationalcancerdatabase
AT auritsarahj primarysiteandotherprognosticfactorsforfibrosarcomaananalysisofthenationalcancerdatabase
AT silbersteinpetert primarysiteandotherprognosticfactorsforfibrosarcomaananalysisofthenationalcancerdatabase
AT gooteejonathan primarysiteandotherprognosticfactorsforfibrosarcomaananalysisofthenationalcancerdatabase